Cetera Advisor Networks LLC Has $3.81 Million Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Cetera Advisor Networks LLC boosted its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report) by 10.2% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 42,706 shares of the exchange traded fund’s stock after buying an additional 3,956 shares during the period. Cetera Advisor Networks LLC’s holdings in SPDR S&P Biotech ETF were worth $3,813,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of XBI. EPG Wealth Management LLC raised its holdings in SPDR S&P Biotech ETF by 152.7% during the 3rd quarter. EPG Wealth Management LLC now owns 460 shares of the exchange traded fund’s stock worth $34,000 after buying an additional 278 shares during the period. BOCHK Asset Management Ltd bought a new position in shares of SPDR S&P Biotech ETF during the 4th quarter worth approximately $36,000. Tennessee Valley Asset Management Partners bought a new position in shares of SPDR S&P Biotech ETF during the 4th quarter worth approximately $44,000. Wetzel Investment Advisors Inc. bought a new position in shares of SPDR S&P Biotech ETF during the 4th quarter worth approximately $45,000. Finally, Concourse Financial Group Securities Inc. grew its stake in shares of SPDR S&P Biotech ETF by 21.2% during the 4th quarter. Concourse Financial Group Securities Inc. now owns 658 shares of the exchange traded fund’s stock worth $59,000 after acquiring an additional 115 shares in the last quarter.

SPDR S&P Biotech ETF Stock Up 0.7 %

Shares of XBI opened at $92.01 on Tuesday. The stock has a market capitalization of $7.01 billion, a P/E ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a twelve month low of $63.80 and a twelve month high of $103.52. The company has a 50 day moving average of $88.89 and a 200-day moving average of $89.43.

SPDR S&P Biotech ETF Profile

(Free Report)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Further Reading

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.